Al Pacino To Appear in US Theaters Exclusive One Night

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Al Pacino To Appear in US Theaters Exclusive One Night Event

NATIONAL IN-THEATER SCREENING SERIES MARCH 24TH TO FEATURE "DANNY COLLINS" WITH EXCLUSIVE CAPTURED LIVE APPEARANCE BY OSCAR® WINNING AL PACINO

SPONSORED BY CITI® PRIVATE PASS®

NEW YORK, N.Y., March 20, 2015 (GLOBE NEWSWIRE) -- The New York Film Critics Series® (NYFCS® www.nyfilmcriticsseries.com ), one of the leading word-of-mouth screening companies, has partnered with the nation's leading independent cinemas to present live, national, in-theater screenings. The events are moderated by Peter Travers, film critic for Rolling Stone Magazine and ABC's Popcorn, along with additional coverage by Alison Bailes of BBC, More Magazine, WOR Radio, and The Charlie Rose Show. The series presents live, interactive, in-theater; pre-release movies and big screen HD simulcast with the stars and filmmakers.

We're excited to announce our next NYFCS film screening will be Bleecker Street's "DANNY COLLINS". The pre-release screening and event will take place captured live throughout the country on Tuesday March 24th, 2015. The event will feature a captured live broadcast with Al Pacino. Citi® is the Official Card of this event.

DANNY COLLINS is inspired by a true story about an aging rock star who decides to change his life when he discovers a 40-year old letter written to him by John Lennon. Starring: Al Pacino, Annette Bening, Christopher Plummer, Jennifer Garner, Bobby Cannivale. Written and directed by Dan Fogelman. The movie features songs by John Lennon.

The NYFCS® event will include an exclusive, captured live, interactive, HD Simulcast to 50 U.S. locations. The series takes place exclusively in theaters and is never available on TV or the internet. US Locations

Up until now, live talent has only been accessible to the public in NY, LA and at festivals. Now everyone throughout the country can enjoy up close and personal moments from major movie stars, producers, writers and directors in the comfort of their own neighborhood theaters. Regional preview screenings are happening all the time, but never with a live, talent conversation component. This is a comprehensive, industry wide turn-key marketing tool complete with robust media and in-theater assets to 400+ screens.

A regular series of ongoing preview screenings is established in 50 select major markets. Audiences experience all of the excitement of live Q &A sessions, hosted by Peter Travers. The big screen events deliver 9-13 curated pre-release films per year to discerning audiences on a monthly basis. Each film in the screening series is introduced live by Peter Travers. Audiences then see the best films prior to their release followed by live, HD Q &A between Travers, audiences and talent from the films. Each piece brings the energy and VIP nature of prestigious, NYC screenings for nationwide audiences to interact with stars and directors via two-way simulcast.

This is the first ever live national in-theater screening series which will entertain, educate, surprise, and refresh the spirit of true independent and foreign language filmmaking through provocative story-telling. The NYFCS® is dedicated to producing inspiring events in a collaborative environment and to nurturing the long-term success of movies. Featuring an energetic, creative, and experienced team, the NYFCS® exhibits socially and culturally relevant films with live world-class talent in the best independent theaters throughout the US. Citi® Private Pass® is sponsoring this NYFCS® event. This relationship was arranged by The Erlick Group a leading NYC-based entertainment sponsorship agency that has represented leading properties in film, music, theatre and venues for the past 22 years.

PAST SCREENINGS

Al Pacino – DANNY COLLINS 3/24
Russell Crowe – WATER DIVINER – 4/23
Jennifer Anniston – CAKE
Shirley MacLaine – ELSA & FRED
Rob Reiner – AND SO IT GOES
Daniel Radcliffe (Harry Potter) – WHAT IF
Gillian Flynn –GONE GIRL
James Franco – CHILD OF GOD
Andy Garcia – AT MIDDLETON
Tom Hardy (Bain from BATMAN) – LOCKE
Jon Favreau – CHEF
Felicity Huffman – BREATHE
David O. Russell – Director AMERICAN HUSTLE

About The New York Film Critics Series®:

Peter Travers, Host: Peter is an American film critic, who has written for, in turn, People and Rolling Stone. Travers also hosts a celebrity interview show called Popcorn on ABC News Now and ABCNews.com. Travers joined Rolling Stone in 1989 after a four-year stint with People. He's best known for his basic writing style that eschews a more sophisticated analysis for an easy-to-read and often very opinionated form. According to efilmcritic.com, Travers is the nation's most blurbed film critic. Peter has hosted the NYFCS for over 10 years. In addition to Rolling Stone Magazine, ABC-TV, Peter appears regularly on Newsweek & The Daily Beast, The Soho Apple Store, and CNN.

Alison Bailes, Co-Host: Alison is the film critic for BBC, More Magazine and a contributing critic for "Ebert Presents at the Movies" on PBS. She appears on NBC's Today Show as a film critic and industry reporter. Alison also appears regularly on Charlie Rose along with A.O. Scott of the NY times and others. She guest hosts the New York Film Critics Series® and maintains her own film website: www.alisonbailes.com

From 2005-2009 Alison co-hosted the NBC Universal weekly movie review show "Lyons & Bailes Reel Talk". She and Jeffrey Lyons shared their different perspectives on the latest film and DVD releases, gave viewers the latest news from the box office and reported on industry trends. "Reel Talk" also featured celebrity interviews. Prior to joining WNBC, Alison created "At The Angelika" for the Independent Film Channel. She wrote, produced and hosted this monthly look at the independent film scene, which later became known as "At The IFC Center." Previously, Alison was a senior producer of the weekly film magazine show, "Flix" on VH1. She began her career at CNN, working for their daily entertainment news show "Showbiz Today." A UK native, Alison has lived in the United States since 1989. She graduated from Oxford University, with a Bachelor of Arts degree in French and German Literature.

Independent Theaters: The NYFCS® network of U.S. theaters are independent partners that are dedicated to presenting the finest films available. These are exhibitors who take great pride in their shows and provide patrons with state-of-the-art, live HD experiences in the comfort of their convenient locations. Each location has been carefully chosen to ensure the best possible experience that is available in domestic, independent cinema today.

Bleecker Street Media, LLC is a film studio dedicated to bringing smart and inviting entertainment to discerning audiences. Upcoming releases include: Danny Collins, directed by Dan Fogelman (writer of Crazy, Stupid, Love), starring Al Pacino, Annette Bening,Jennifer Garner, Bobby Cannavale and Christopher Plummer; I'll See You In My Dreams, directed by Brett Haley, starring Blythe Danner, Martin Starr, Sam Elliott, Malin Ackerman, June Squibb, Rhea Perlman, and Mary Kay Place; Captain Fantastic, directed by Matt Ross (28 HOTEL ROOMS), starring Viggo Mortensen, Frank Langella, Kathryn Hahn, Missi Pyle, and Steve Zahn; Pawn Sacrifice, directed by Edward Zwick (Blood Diamond), starring Tobey Maguire, Liev Schreiber, and Peter Sarsgaard; and Trumbo, directed by Jay Roach (Game Change), starring Bryan Cranston, Helen Mirren, Diane Lane, and Elle Fanning.

Mark Ehrenkranz

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Cottage Grove Tests Holiday Demand Across Lake Norman

Updated Category News Views 125

Flour and foot traffic make a pretty honest little scoreboard. Cottage Grove Bakery is putting itself in front of Lake Norman shoppers twice on Saturday, November 21, while also taking Thanksgiving orders and laying groundwork for 2027 workplace and school visits. This is not a public-company earnings story, and nobody should pretend a tray of scones is a quarterly...

Continue Reading
PexarBolt's CES Honor Meets a Real Crowdfunding Test

Updated Category News Views 77

A little touchscreen bolted onto a dock would usually make me roll my eyes. This time, Pexar has at least put enough muscle behind the gimmick to deserve a harder look. The PexarBolt Ultra TBT5 Dock was named a CES Innovation Awards 2027 Honoree in Computer Peripherals & Accessories, following an IFA 2026 Innovation Awards honor only two months after its launch. Awards do...

Continue Reading
Tessera Delisting Leaves HLSQ in a Tougher Market Ahead

Updated Category News Views 116

November delivered a nasty little truth serum for Tessera Defense and Homeland Security: exchange status is not a cosmetic detail when the stock’s selling price has collapsed. On November 10, NYSE Regulation suspended trading in the company’s common shares on NYSE American and began delisting proceedings. By November 17, Tessera had a chance to request review by the...

Continue Reading
Six LIFE Photographers Bring History Into Florida Focus

Updated Category News Views 72

Seventy photographs can make a pretty loud argument when the historical record has been this lopsided. The Ashley Gibson Barnett Museum of Art at Florida Southern College has brought LIFE: Six Women Photographers to Lakeland, and it deserves more than the usual polite nod given to a traveling museum show. Open since November 14, 2026, and running through March 7, 2027,...

Continue Reading
Simmons Clarifies Texas Loan Exposure, But Risks Remain

Updated Category News Views 87

A $45 million discrepancy is not a rounding error, and Simmons First National has every reason to swat it down hard. The bank says recent reporting overstated financing tied to a Texas multifamily development at $133 million. Its stated total is roughly $88 million, with about $44 million participated to another financial institution. For shareholders in NASDAQ:SFNC, that...

Continue Reading
Greenberg Traurig Adds Privacy Muscle in Denver Office

Updated Category News Views 162

Privacy work used to be the legal department's back-room plumbing; now it can jam an entire product launch. That is why Greenberg Traurig's decision to bring Amber Mednick in as of counsel in Denver deserves more attention than the usual law-firm hiring blurb. This is not a splashy deal, and nobody should pretend one lateral hire rewrites the competitive map. Still, it is...

Continue Reading
Sitting, Lymph Flow, and a Supplement Maker's Pitch

Updated Category News Views 32

By late afternoon, a chair can feel like it has quietly won the argument against your legs. PureHealth Research is leaning into that familiar heavy, puffy-legged feeling with a reminder about lymphatic flow—and, naturally, an eight-ingredient supplement positioned alongside it. The broad message is sensible. The sales layer needs the usual healthy squint. Movement Does...

Continue Reading
OU's $44.3M Rural Care Plan Targets Oklahoma Care Gaps

Updated Category News Views 100

A Long Drive Is a Brutal Barrier to Care Seventy-five of Oklahoma's 77 counties sit in health professional shortage territory, a figure that ought to stop people cold. It means at least 3,500 patients per provider in those counties. That is not some abstract planning headache. It is the pregnant patient delaying a specialist visit, the family weighing an ambulance ride,...

Continue Reading
Faex Health Adds Ebola and H. pylori AI Screening Tools

Updated Category News Views 82

A smartphone pointed at a toilet is an awkward place to hunt for medical progress, yet Faex Health is making a serious attempt to turn that daily evidence into an early-warning tool. The company has added investigational pre-screening capabilities for Ebola virus disease and Helicobacter pylori, or H. pylori, bringing its internally validated panel to 18 gastrointestinal...

Continue Reading
Fluence Investors Face a November 27 Litigation Clock

Updated Category News Views 40

Six calendar squares are all that separate eligible Fluence investors from the November 27, 2026 lead-plaintiff deadline. That is not much time to locate trade confirmations, calculate losses, and decide whether taking a larger role in a securities case makes sense. The lawsuit is not a verdict, and anybody pretending otherwise is selling smoke. But the underlying...

Continue Reading

Top 5 Most Recently Viewed Articles

Significant Unusual Options Activity Signals Opportunity in GOOGL

Updated Category News Views 97

Analyzing Recent Options Activity for Alphabet Currently, investors are exhibiting a strong bullish sentiment towards Alphabet (NASDAQ: GOOGL), a trend that is capturing the attention of market participants. Recent observations of public options have revealed significant movements in GOOGL, hinting at potential changes ahead. Recent analyses have uncovered 129 unusual...

Continue Reading
Encore and UKG Introduce Innovative Overtime Savings Program

Updated Category News Views 298

Encore and UKG Join Forces for Employee Financial Wellness Encore, a prominent global leader in event technology and production services, has unveiled an innovative ‘Overtime Savings Program’ in collaboration with UKG, a top provider of HR and workforce management solutions. This remarkable initiative aims to empower Encore's frontline workers, allowing them to save...

Continue Reading
Discover Incredible Returns from Texas Pacific Land Investments

Updated Category News Views 160

The Incredible Growth of Texas Pacific Land Corp Texas Pacific Land Corp (NYSE: TPL) has marked its presence in the market with an outstanding performance over the past 15 years. The company has outshone the market median by an impressive 32.71% annually, which translates to a staggering average annual return of 45.46%. With a current market capitalization nearing $20.51...

Continue Reading
Cypherpunk Q2 2026: Zcash Growth Sparks Market Buzz

Updated Category News Views 76

Cypherpunk Technologies' Stellar Q2 Performance Sit tight, folks, because Cypherpunk Technologies just unleashed a financial update that's got the market buzzing. They've reported a staggering net income of $39.4 million for Q2 2026, quite the turnaround from a $16.6 million loss in the same quarter last year. It's a serious win, no doubt pumped up by their fruitful Zcash...

Continue Reading
Exciting Findings from Aicuris’ Clinical Trials of AIC468

Updated Category News Views 182

Encouraging Insights into AIC468 from Clinical Trials Recently, a notable advancement in medical research has emerged from Aicuris Anti-infective Cures AG regarding its novel treatment, AIC468. This drug is an innovative antisense oligonucleotide targeting the BK virus, particularly in kidney transplant recipients. The first-in-human (FIH) Phase 1 trial has provided...

Continue Reading